Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Functional investigation of inherited noncoding genetic variation impacting the pharmacogenomics of childhood acute lymphoblastic leukemia treatment

medRxiv(2023)10.1101/2023.02.10.23285762Source: DataRank Database

Functional investigation of inherited noncoding genetic variation impacting the pharmacogenomics of childhood acute lymphoblastic leukemia treatment is a research paper published in medRxiv (2023). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Download PDF

Cite:

Linked data & code

refsnp

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (13 grants)OA: greenTopics (18)IDs (PubMed, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (24)

Robert J. Mobley ORCID,Kelly R. Barnett ORCID,Daniel C. Ferguson ORCID,Baranda S. Hansen ORCID,Jonathan D. Diedrich ORCID

Live enrichment

PubMed:36798219 OpenAlex:https://openalex.org/W4320033868

National Institutes of Health

Grant: 3UG1CA232760-06S1

NCI, National Clinical Trials Network Lead Academic Participating Site (LAPS) UG1 (funded extension)

National Institutes of Health

Grant: 5R01CA234490-02

Characterizing noncoding GWAS variants in acute lymphoblastic leukemia treatment outcome

National Institutes of Health

Grant: 3U10CA180820-02S3

ECOG-ACRIN Operations Center

National Institutes of Health

Grant: 5P50GM115279-03

Center for Precision Medicine in Leukemia (CPML)

National Institutes of Health

Grant: 5UG1CA189859-03

Minority-Based Community Oncology Research Program

National Institutes of Health

Grant: 3P30CA021765-41S2

Cancer Center Support Grant (CCSG)

NCI NIH HHS

Grant: U24 CA196172

NCI NIH HHS

Grant: UG1 CA232760

NCI NIH HHS

Grant: P30 CA021765

NCI NIH HHS

Grant: U10 CA180820

NIGMS NIH HHS

Grant: P50 GM115279

NCI NIH HHS

Grant: R01 CA234490

NCI NIH HHS

Grant: UG1 CA189859

greenLicense: cc-by-nc-nd

repositoryhttps://www.medrxiv.org/content/medrxiv/early/2023/02/11/2023.02.10.23285762.full.pdf

publisherhttps://syndication.highwire.org/content/doi/10.1101/2023.02.10.23285762

repositoryhttps://doi.org/10.1101/2023.02.10.23285762

repositoryhttps://pubmed.ncbi.nlm.nih.gov/36798219

Fields of Study

Acute Lymphoblastic Leukemia researchEpigenetics and DNA MethylationDNA Repair Mechanisms0301 basic medicine0303 health sciences03 medical and health sciences

Keywords

PharmacogenomicsBiologyAlleleGeneGeneticsGenetic variationDrug resistanceChildhood leukemiaComputational biologyLeukemiaLymphoblastic LeukemiaArticle

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Functional investigation of inherited noncoding genetic variation impacting the pharmacogenomics of childhood acute lymphoblastic leukemia treatment

FAIR Checklist

Authors (24)

Funding (13 grants)

Open Access

Topics

Annotations (Europe PMC)